Novel Microdevices
PrivateLast Round
Seed Round
Mar 27, 2026
Total Funding Raised
$24.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Novel Microdevices operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Grant round in June 2025.
Novel Microdevices is a diagnostic equipment company that develops a handheld point-of-care medical device designed to facilitate molecular diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novel Microdevices Comparables
Compare Novel Microdevices with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prompt Diagnostics | 92% | |
| Nuclein | 87% | |
| FlashDx Inc. | 85% |
For institutional investors. Book with your work email.
Novel Microdevices Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 27, 2026 | ||||
| Grant | Jun 19, 2025 | ||||
| Early Funding | Feb 18, 2025 | ||||
| VC Round | Feb 18, 2025 | ||||
| Grant | Nov 8, 2024 | ||||
Early Funding | Dec 28, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novel Microdevices Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| NIH RADx | Grant |
| TEDCO | Series A, Early Funding, VC Round, Pre Seed |
| Maryland Department of Commerce | Grant |
| Old Line Capital Partners | Series A |
| National Institutes of Health (NIH) | Grant |
| Ecphora Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 27, 2026
$1M raised in Seed Round.
- Jun 19, 2025
$634K grant received from Maryland Department of Commerce.
For institutional investors. Book with your work email.
Novel Microdevices Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novel Microdevices's valuation, stock price, and market status.
Is Novel Microdevices a public or private company?
Novel Microdevices is a private company.
What is the current stock price of Novel Microdevices?
Novel Microdevices is a private company, so its shares have no public market price. Caplight tracks Novel Microdevices's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novel Microdevices worth (valuation)?
Valuation information for Novel Microdevices is not publicly available.
Can I buy Novel Microdevices stock?
Novel Microdevices shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novel Microdevices's last funding round?
Novel Microdevices's most recent funding round was Seed Round on March 27, 2026.
Who are the main investors in Novel Microdevices?
Key investors in Novel Microdevices include TEDCO.
Will Novel Microdevices IPO soon?
No public IPO plans have been announced for Novel Microdevices.
How can I track Novel Microdevices secondary market activity?
Caplight tracks bids, offers, and trades in Novel Microdevices's shares on secondary markets.